Back
HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 1409776Generated: October 27, 2026

Chloro-N,N,N',N'-tetramethylformamidinium Hexafluorophosphate → 5-Oxazol-5-yl-pyrazine-2-carboxylic acid cyclopropyl-[1-(3-isopropyl-[1,2,4]oxadiazol-5-yl)-piperidin-4-yl]amide

https://huagongshe.com/reaction/1409776

Reaction equation

Participants

RoleNameHCIDCharge
ReactantChloro-N,N,N',N'-tetramethylformamidinium HexafluorophosphateHCID 10989639—
ReactantN-cyclopropyl-1-(3-isopropyl-1,2,4-oxadiazol-5-yl)piperidin-4-amineHCID 68290028—
Reactant5-Oxazol-5-yl-pyrazine-2-carboxylic acidHCID 86686158—
SolventTetrahydrofuranHCID 8028—
Product5-Oxazol-5-yl-pyrazine-2-carboxylic acid cyclopropyl-[1-(3-isopropyl-[1,2,4]oxadiazol-5-yl)-piperidin-4-yl]amideHCID 86686181—

Reaction Steps

The title compound is prepared from cyclopropyl-[1-(3-isopropyl-[1,2,4]oxadiazol-5-yl)-piperidin-4-yl]-amine and 5-oxazol-5-yl-pyrazine-2-carboxylic acid following a procedure analogous to that described in Example 1 using chloro-N,N,N′,N′-tetramethylformamidinium hexafluorophosphate as reagent and tetrahydrofuran as solvent. LC (method 8): tR=1.47 min; Mass spectrum (ESI+): m/z=424 [M+H]+.

Provenance & Evidence

DOI10.6084/m9.figshare.5104873.v1
Patent numberUS08921398B2
Source datasetuspto-grants-2014_12
ORD IDord-8f529d8125024ed99796c4d8ba03de07
Source noteuspto-grants-2014_12